Calgb30610- Phase III Comparison Of Thoracic Radiotherapy Regimens In Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin And Etoposide
Posted Date: May 15, 2019
- Investigator: Kevin Redmond
- Specialties: Cancer, Lung Cancer, Oncology
- Type of Study: Drug
The goal of this study is To determine whether administering high dose thoracic radiotherapy, 70 Gy (2 Gy once-daily over 7 weeks) or 61.2 Gy (1.8 Gy once-daily for 16 days followed by 1.8 Gy twice-daily for 9 days), will improve median and 2-year survival compared with 45 Gy (1.5 Gy twice-daily over 3 weeks) in patients with limited stage small cell lung cancer.
Criteria:
To Be Eligible: Diagnosed With Small Cell Lung Cancer, >18 Years Of Age, No Prior Treatment For Sclc, Nonpregnant/Nonbreastfeeding
Keywords:
Calgb30610, Limited Small Cell L, Lung Cancer, Sclc, Thoracic Cancer
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com